GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Calmer Co International CCO.AX · AUD

Consumer Staples · ASX · 🇦🇺 Australia

Compare

0.00

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Calmer Co International

Its shares trade on ASX under the ticker CCO.AX. It has been listed since 20 December 2018. In the fiscal year to 30 June 2026, it reported revenue of A$8.1m and a net loss of A$3.8m. At that date it held total assets of A$4.9m and shareholders' equity of −A$451,341.

The Calmer Co International Ltd. is a biotechnology company, which engages in the selling kava extracts. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-20. The Company’s solutions include kava, cannabis, turmeric, and ginger. Its brands include fijikava, taki mai, and danodan. Its danodan calm is for strength against occasional stress and tension. Its danodan energy is for stamina, vitality, and focus. Its danodan active is for exercise recovery. Its danodan sleep is a formula for nightly sleep support. The firm builds lifestyle brands in shots, juice, RTD functional beverages.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
20 Dec 2018

Leadership

Pay as last reported

  • Mr. John HomewoodNon-Executive Chairman of the Board
  • Mr. Zane YoshidaChief Executive Officer, Managing Director, Executive Director, since 2018A$234,853
  • Mr. Brian CasuttoManaging Director - USA
  • Mr. Matthew KowalChief Commercial Officer
  • Ms. Natalie ClimoCompany Secretary
  • Mr. Griffon EmoseNon-Executive Director
  • Dr. Anthony NobleNon-Executive Director
  • Mr. James TonkinNon-Executive Director
  • Mr. Jack LowensteinIndependent Non-Executive Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Calmer Co International Ltd's kava extracts are sold in Australia and New Zealand markets.
  • The company's danodan calm brand targets stress relief with natural solutions.
  • Calmer Co's product range includes kava, cannabis, turmeric, and ginger extracts.

Weaknesses

  • The company's IPO listing date is 20 December 2018, which is a fixed historical fact.
  • Calmer Co's business is limited to Consumer Staples sector with no diversification.
  • The company's headquarters in Brisbane, Queensland, may limit global expansion opportunities.

Opportunities

  • Expanding danodan energy brand into the US market for stamina and focus products.
  • Increasing kava extract sales in the European Union through new distribution channels.
  • Growing demand for natural stress relief products in the Asia-Pacific region.

Threats

  • Regulatory challenges for cannabis-based products in the United States market.
  • Competition from established health beverage brands in the European Union.
  • Potential market saturation in the Australian Consumer Staples sector.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.